Date Field | Doc. No. | Description (Pages) |
---|
Apr 5, 2023 | 16 | Report to the Commissioner of Patents and Trademarks. (ntl) (Entered: 04/05/2023) (3) |
Apr 4, 2023 | 15 | STIPULATION of Dismissal without prejudice pursuant to Fed. R. Civ. P. 41(a) by ACADIA Pharmaceuticals Inc.. (Streifthau-Livizos, Michelle) (Entered: 04/04/2023) (2) |
Feb 2, 2023 | 14 | MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, James T. Peterka, Timothy F. Peterson, August M. Melcher and Amy Lange - filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Attachments: # 1 Certification of Michael J. Gaertner, # 2 Certification of James T. Peterka, # 3 Certification of Timothy F. Peterson, # 4 Certification of August M. Melcher, # 5 Certification of Amy Lange)(Bilson, David) (Entered: 02/02/2023) (Main Document) (2) |
Feb 2, 2023 | 14 | MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, James T. Peterka, Timothy F. Peterson, August M. Melcher and Amy Lange - filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Attachments: # 1 Certification of Michael J. Gaertner, # 2 Certification of James T. Peterka, # 3 Certification of Timothy F. Peterson, # 4 Certification of August M. Melcher, # 5 Certification of Amy Lange)(Bilson, David) (Entered: 02/02/2023) (Certification of Michael J. Gaertner) (1) |
Feb 2, 2023 | 14 | MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, James T. Peterka, Timothy F. Peterson, August M. Melcher and Amy Lange - filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Attachments: # 1 Certification of Michael J. Gaertner, # 2 Certification of James T. Peterka, # 3 Certification of Timothy F. Peterson, # 4 Certification of August M. Melcher, # 5 Certification of Amy Lange)(Bilson, David) (Entered: 02/02/2023) (Certification of James T. Peterka) (1) |
Feb 2, 2023 | 14 | MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, James T. Peterka, Timothy F. Peterson, August M. Melcher and Amy Lange - filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Attachments: # 1 Certification of Michael J. Gaertner, # 2 Certification of James T. Peterka, # 3 Certification of Timothy F. Peterson, # 4 Certification of August M. Melcher, # 5 Certification of Amy Lange)(Bilson, David) (Entered: 02/02/2023) (Certification of Timothy F. Peterson) (1) |
Feb 2, 2023 | 14 | MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, James T. Peterka, Timothy F. Peterson, August M. Melcher and Amy Lange - filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Attachments: # 1 Certification of Michael J. Gaertner, # 2 Certification of James T. Peterka, # 3 Certification of Timothy F. Peterson, # 4 Certification of August M. Melcher, # 5 Certification of Amy Lange)(Bilson, David) (Entered: 02/02/2023) (Certification of August M. Melcher) (1) |
Feb 2, 2023 | 14 | MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, James T. Peterka, Timothy F. Peterson, August M. Melcher and Amy Lange - filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Attachments: # 1 Certification of Michael J. Gaertner, # 2 Certification of James T. Peterka, # 3 Certification of Timothy F. Peterson, # 4 Certification of August M. Melcher, # 5 Certification of Amy Lange)(Bilson, David) (Entered: 02/02/2023) (Certification of Amy Lange) (1) |
Jan 30, 2023 | 11 | ANSWER to 1 Complaint Affirmative Defenses by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc..(Bilson, David) (Entered: 01/30/2023) (17) |
Jan 30, 2023 | 12 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Zydus Lifesciences Limited for Zydus Pharmaceuticals (USA) Inc. filed by Zydus Pharmaceuticals (USA) Inc.. (Bilson, David) (Entered: 01/30/2023) (2) |
Jan 30, 2023 | 13 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Zydus Lifesciences Limited. (Bilson, David) (Entered: 01/30/2023) (2) |
Dec 19, 2022 | 10 | NOTICE requesting Clerk to remove Aubrey J. Morin as co-counsel. Reason for request: No longer with the firm of Saul Ewing LLP. (Streifthau-Livizos, Michelle) (Entered: 12/19/2022) (1) |
Dec 9, 2022 | 9 | STIPULATION TO EXTEND TIME Defendants to respond to complaint to January 30, 2023 - filed by ACADIA Pharmaceuticals Inc.. (Streifthau-Livizos, Michelle) (Entered: 12/09/2022) (2) |
Dec 2, 2022 | 8 | MOTION for Pro Hac Vice Appearance of Attorney Bruce M. Wexler, Chad J. Peterman, Scott F. Peachman, Rebecca A. Hilgar and Felix A. Eyzaguirre - filed by ACADIA Pharmaceuticals Inc.. (Streifthau-Livizos, Michelle) (Entered: 12/02/2022) (7) |
Nov 8, 2022 | 6 | WAIVER OF SERVICE returned executed by ACADIA Pharmaceuticals Inc.: For Zydus Lifesciences Limited waiver sent on 11/1/2022, answer due 1/3/2023. (Streifthau-Livizos, Michelle) (Entered: 11/08/2022) (1) |
Nov 8, 2022 | 7 | WAIVER OF SERVICE returned executed by ACADIA Pharmaceuticals Inc.: For Zydus Pharmaceuticals (USA) Inc. waiver sent on 11/1/2022, answer due 1/3/2023. (Streifthau-Livizos, Michelle) (Entered: 11/08/2022) (1) |
Oct 24, 2022 | 5 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by ACADIA Pharmaceuticals Inc.. (Streifthau-Livizos, Michelle) (Entered: 10/24/2022) (2) |
Oct 21, 2022 | 1 | Complaint* (1) |
Oct 21, 2022 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 10/24/2022) (3) |
Oct 21, 2022 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: See Attached. Date of Expiration of Patent: See Attached. (mpb) (Entered: 10/24/2022) (2) |
Oct 21, 2022 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,452,721. (mpb) (Entered: 10/24/2022) (1) |